Description

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3)

IGF-1 LR3 is a modified analog of insulin-like growth factor-1 engineered for extended stability and prolonged activity in research settings. This synthetic peptide features an arginine substitution at position 3 and an additional 13–amino acid extension, significantly reducing its binding affinity to IGF-binding proteins and increasing its half-life compared to native IGF-1.

Widely studied in biochemical and cellular research, IGF-1 LR3 is commonly utilized in investigations involving cell proliferation, differentiation, and metabolic signaling pathways.

Key Features

• Extended half-life vs. native IGF-1

• Reduced binding to IGF-binding proteins (IGFBPs)

• High purity, research-grade peptide

• Stable structure suitable for controlled laboratory applications

Research Applications

IGF-1 LR3 is frequently used in studies related to:

• Cellular growth and replication mechanisms

• Protein synthesis pathways

• Tissue regeneration models

• Metabolic and endocrine signaling research

Product Specifications

• Sequence Modification: Arg3 substitution + N-terminal extension

• Form: Lyophilized powder

• Purity: ≥98% (HPLC verified)

• Storage: Store at -20°C in a dry, stable environment

• Reconstitution: Typically reconstituted with bacteriostatic water for research use

Important Notice

This product is intended for laboratory research purposes only. Not for human consumption, medical use, or veterinary application. All purchasers must be qualified professionals operating within a legitimate research setting.